Qulali M, Crabb D W
Department of Medicine, Indiana University School of Medicine, Indianapolis 46202-5121.
Alcohol Clin Exp Res. 1992 Jun;16(3):427-31. doi: 10.1111/j.1530-0277.1992.tb01394.x.
Glucocorticoids induced ADH activity and mRNA 2- to 4-fold in rat hepatoma cells (H4IIE and H4IIEC3), but were reported not to alter ADH activity in rat liver. The failure of corticosteroids to induce ADH may have been due to the short-term treatment of the rats or the dose of steroid used. To reevaluate the effect of glucocorticoids in vivo, we studied animals 4.5 weeks after adrenalectomy so that ADH activity and mRNA should have reached a new steady-state level; the dose of glucocorticoid used was estimated to provide physiological replacement. Male Wistar rats were injected with a single daily dose (10 mg/kg/day) of corticosterone-21-acetate or vehicle subcutaneously for 10 days. Liver extracts were assayed for ADH activity, ADH protein, and ADH mRNA. Nuclei were isolated for nuclear run-on assays. Adrenalectomy did not reduce the activity of ADH in liver. Subsequent corticosterone treatment did not alter ADH enzyme activity, nor did it affect ADH protein levels as analyzed on Western blots. However, Northern blot analysis of ADH mRNA indicated a 2-fold increase in ADH mRNA in the treated animals when the data were normalized to the level of the 28S ribosomal RNA or CHO-B mRNA. The rate of transcription of the ADH gene in nuclei isolated at the end of 10 days of treatment from corticosterone-treated adrenalectomized rats was not statistically different from that in the oil-treated adrenalectomized ones. The disparity between ADH activity and protein levels and the mRNA level may have resulted from other effects of corticosterone, e.g., stimulation of protein degradation or effects on translation.
糖皮质激素可使大鼠肝癌细胞(H4IIE和H4IIEC3)中的抗利尿激素(ADH)活性和mRNA增加2至4倍,但据报道其不会改变大鼠肝脏中的ADH活性。糖皮质激素未能诱导ADH产生,可能是由于对大鼠的短期治疗或所用类固醇的剂量所致。为了重新评估糖皮质激素在体内的作用,我们研究了肾上腺切除术后4.5周的动物,以使ADH活性和mRNA达到新的稳态水平;所用糖皮质激素的剂量估计可提供生理替代。雄性Wistar大鼠皮下注射单剂量(10mg/kg/天)的醋酸皮质酮-21-醋酸酯或赋形剂,持续10天。对肝脏提取物进行ADH活性、ADH蛋白和ADH mRNA检测。分离细胞核用于核转录分析。肾上腺切除术并未降低肝脏中ADH的活性。随后的皮质酮治疗并未改变ADH酶活性,也未影响Western印迹分析的ADH蛋白水平。然而,当将数据标准化为28S核糖体RNA或CHO-B mRNA水平时,ADH mRNA的Northern印迹分析表明,治疗动物的ADH mRNA增加了2倍。在皮质酮治疗的肾上腺切除大鼠治疗10天结束时分离的细胞核中,ADH基因的转录速率与油处理的肾上腺切除大鼠相比无统计学差异。ADH活性、蛋白水平与mRNA水平之间的差异可能是由皮质酮的其他作用导致的,例如刺激蛋白质降解或对翻译的影响。